Live Quote · OTCGTHPHealthcare· Medical - Devices

Guided Therapeutics, Inc.

$0.28 14.29%(+$0.04)
TickerSpark Score
57/100
Mixed
27
Valuation
60
Profitability
80
Growth
36
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GTHP research report →

52-Week Range38% of range
Low
$0.12
Current
$0.28
High
$0.54
Company Overviewwww.guidedinc.com

About the company

Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer.

CEO
Mark L. Faupel
IPO
2021
Employees
4
HQ
Norcross, GA, US

Price Chart

+5.46% · this period
$0.54$0.34$0.14Jul 02Dec 31Jul 02
Valuation
Market Cap
$21.48M
P/E
-6.28
P/S
28.00
P/B
-4.81
EV/EBITDA
-8.80
Div Yield
0.00%
Profitability
Gross Margin
67.93%
Op Margin
-322.95%
Net Margin
-512.65%
ROE
70.53%
ROIC
103.60%
Growth & Income
Revenue
$767.00K · 10857.14%
Net Income
$-3,196,000 · -32.23%
EPS
$-0.04 · 5.53%
Op Income
$-2,372,000
FCF YoY
4.38%
Performance & Tape
52W High
$0.54
52W Low
$0.12
50D MA
$0.22
200D MA
$0.28
Beta
0.73
Avg Volume
14.06K

Get TickerSpark's AI analysis on GTHP

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 26, 26Blumberg Richard P.other352,000
Mar 26, 26Blumberg Richard P.other19,038
Mar 26, 26Blumberg Richard P.other1,040,000
Mar 26, 26Blumberg Richard P.other56,093
Feb 25, 26Blumberg Richard P.other1,000,000
Mar 1, 26Blumberg Richard P.other900,000
Feb 25, 26Blumberg Richard P.other1,000,000
Feb 25, 26Blumberg Richard P.other1,000,000
Mar 10, 26Blumberg Richard P.other110,000
Feb 25, 26Blumberg Richard P.sell1,000,000
Coverage · GTHP

Our GTHP coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on GTHP yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate GTHP report →
Internal Compare

Similar companies

Peers in the same neighborhood.